Lingpeng Zhu Selected Research

rhodioloside

1/2021	Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis.
1/2020	Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis.
3/2019	Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways.
11/2016	Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia.
7/2016	Cardioprotective effects of salidroside on myocardial ischemia-reperfusion injury in coronary artery occlusion-induced rats and Langendorff-perfused rat hearts.
4/2016	Salidroside ameliorates arthritis-induced brain cognition deficits by regulating Rho/ROCK/NF-κB pathway.
1/2016	Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer's disease via SIRT1/NF-κB pathway.
12/2015	Salidroside Mitigates Sepsis-Induced Myocarditis in Rats by Regulating IGF-1/PI3K/Akt/GSK-3β Signaling.
11/2015	The cardioprotective effect of salidroside against myocardial ischemia reperfusion injury in rats by inhibiting apoptosis and inflammation.
10/2015	Salidroside ameliorates cognitive impairment in a d-galactose-induced rat model of Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lingpeng Zhu Research Topics

Disease

7	Inflammation (Inflammations) 01/2021 - 02/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 10/2015
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016 - 08/2015
3	Arthritis (Polyarthritis) 04/2016 - 02/2015
3	Asthma (Bronchial Asthma) 10/2015 - 02/2015
3	Acute Lung Injury 06/2015 - 12/2014
2	Cognitive Dysfunction 01/2021 - 10/2015
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2020 - 01/2020
2	Reperfusion Injury 07/2016 - 11/2015
2	Neuroinflammatory Diseases 01/2016 - 10/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Retinal Degeneration 01/2022
1	Macular Degeneration (Age-Related Maculopathy) 01/2022
1	Burns 01/2021
1	Corneal Neovascularization 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Fibrosis (Cirrhosis) 03/2019
1	Brain Ischemia (Cerebral Ischemia) 11/2016
1	Experimental Arthritis 04/2016
1	Memory Disorders (Memory Loss) 01/2016
1	Sepsis (Septicemia) 12/2015
1	Myocarditis (Carditis) 12/2015
1	Stomach Ulcer (Gastric Ulcer) 09/2015
1	Eosinophilia 04/2015
1	Neoplasms (Cancer) 12/2014
1	Pulmonary Edema 12/2014

Drug/Important Bio-Agent (IBA)

12	rhodiolosideIBA 01/2021 - 04/2015
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2015
3	LipopolysaccharidesIBA 12/2015 - 12/2014
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2020
2	Retinal Pigments (Pigments, Visual)IBA 01/2022 - 12/2020
2	CytokinesIBA 01/2021 - 04/2015
2	Freund's AdjuvantIBA 04/2016 - 02/2015
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2016 - 10/2015
2	ApigeninIBA 07/2015 - 12/2014
1	2- (1- (3- dimethylaminopropyl)- 5- methoxyindol- 3- yl)- 3- (1H- indol- 3- yl)maleimideIBA 01/2022
1	InterferonsIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Dynamins (Dynamin)IBA 01/2022
1	sodium iodateIBA 01/2022
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 01/2022
1	Aluminum ChlorideIBA 01/2021
1	AlkaliesIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Hyaluronan ReceptorsIBA 01/2021
1	LectinsIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	InflammasomesIBA 01/2021
1	TrypsinIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2019
1	Mitogen-Activated Protein KinasesIBA 03/2019
1	Nuclear Receptor Co-Repressor 1IBA 11/2016
1	Neuroprotective AgentsIBA 11/2016
1	Collagen Type II (Type II Collagen)IBA 04/2016
1	incomplete Freund's adjuvantIBA 04/2016
1	Sirtuin 1IBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	ChloridesIBA 11/2015
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 10/2015
1	ginsenoside Rb1IBA 10/2015
1	Ethanol (Ethyl Alcohol)IBA 09/2015
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 08/2015
1	Diclofenac (SR 38)FDA LinkGeneric 07/2015
1	naringeninIBA 02/2015
1	flavanoneIBA 02/2015
1	naringinIBA 02/2015
1	Antitussive Agents (Antitussives)FDA Link 02/2015
1	Expectorants (Mucolytics)IBA 02/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2014
1	NF-kappa B (NF-kB)IBA 12/2014

Therapy/Procedure

2	Therapeutics 10/2015 - 04/2015
1	Slit Lamp 01/2021
1	Intraperitoneal Injections 12/2015
1	Intradermal Injections 02/2015